DIA, in partnership with the Middle East Regulatory Network (MERN), will host the 9th DIA Middle East Regulatory Conference (MERC) from 1-2 February 2011 in Amman, Jordan.
MERC provides an opportunity for key stakeholders active in the region, including representatives from ministries of health and local and multinational pharmaceutical companies, to exchange views, discuss topics of interest and identify actions to increase patient access to new and improved medicines and therapies. Session topics include:
Local Regulatory Authority Views and Key Issue
- Global Regulatory Environment and Opportunities for the Middle East
- Pre- Post Marketing Safety and Pharmacovigilance
- Falsified Medicines
- Role of Research and Development in Patient Access to New Medicines
- Market Access – Harmonisation of Documentation
- Changing Regulatory Environment
“Since its inception 13 years ago, the Middle East Regulatory Conference has grown to become an important forum for the discussion of matters related to the provision of healthcare in the region,” explains Programme Chairperson Professor Trevor M. Jones, CBE, WHO Commissioner, CIPIH, UK. “MERC brings together all major stakeholders from across the region and Europe to discuss the global regulatory environment and better patient access to new medicines.”
ABOUT DIA: DIA is the global connector in the life sciences product development process. Our association of more than 18,000 members builds productive relationships by bringing together regulators, innovators and influencers to exchange knowledge and collaborate in an impartial setting. DIA’s network creates unparalleled opportunities for the exchange of knowledge and has the interdisciplinary experience to prepare for future developments. The dedicated efforts of DIA staff, members and speakers enable DIA to provide a comprehensive catalogue of conferences, workshops, training courses, scientific publications and educational materials. DIA is a global community representing thousands of stakeholders working together to bring safe and effective products to patients. DIA is an independent, nonprofit organization with its global center in Washington, D.C., USA; regional offices covering North and South America (Horsham, Penn., USA); Europe, North Africa and the Middle East (Basel, Switzerland); and Japan (Tokyo), India (Mumbai) and China (Beijing). For more information, visit www.diahome.org.